A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer's Disease in Taiwan (Q92888742)
Jump to navigation
Jump to search
scientific article published on 05 April 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer's Disease in Taiwan |
scientific article published on 05 April 2019 |
Statements
A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer's Disease in Taiwan (English)
Chiung-Chih Chang
Giia-Sheun Peng
Te-Jen Lai
Chien-Hsun Li